Acetic Acid Otic Solution, USP

Manufacturer
Dispensing Solutions, Inc. | PSS World Medical, Inc.
Effective date
2013-07-12
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:16:58

Label at a glance#

Productacetic acid
Active ingredientACETIC ACID
Label structure12 sections

Indications and uses

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial.

Dosage and administration

Carefully remove all cerumen and debris to allow Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Acetic Acid every 4 to 6 hours. The wick may be removed a...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Acetic Acid Otic Solution, USP is a solution of acetic acid (2%), in a propylene glycol vehicle containing propylene glycol diacetate (3%), benzethonium chloride (0.02%), and sodium acetate (0.015%). The empirical formula for acetic acid is CH3COOH, with a molecular weight of 60.05. The structural formula is:

Acetic AcidAcetic Acid

Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Acetic acid is antibacterial and antifungal; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Hypersensitivity to Acetic Acid or any of the ingredients. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

WARNINGS

WARNINGS SECTION

Discontinue promptly if sensitization or irritation occurs.

PRECAUTIONS

PRECAUTIONS SECTION

Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

PEDIATRIC USE

SPL UNCLASSIFIED SECTION

Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Carefully remove all cerumen and debris to allow Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

HOW SUPPLIED

HOW SUPPLIED SECTION

Acetic Acid Otic Solution, USP containing 2% acetic acid, is available in 15 mL (NDC 55045-1243-00) measured-drop, safety-tip plastic bottles.

STORAGE

SPL UNCLASSIFIED SECTION

Store at 20°- 25°C (68°-77°F). Keep container tightly closed.

Hi-Tech Pharmacal Co., Inc.

Amityville, NY 11701

MG# 28428

Rev. 889:02 11/09

Package Label Principal Display

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 55045-1243-00

NDC 55045-1243-00NDC 55045-1243-00

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
197305acetic acid 2 % Otic SolutionPSN2
197305acetic acid 20 MG/ML Otic SolutionSCD2
197305acetic acid 2 % Otic SolutionSY2

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codePDF417SAMPLE*55045124300NDC 55045-1243-00------HI TECH.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55045-1243-02019-11-27C16284748780-19855d018-e678-cd31-e053-dbdaa90ab51aAcetic Acid Otic Solution, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55045-1243-0acetic acid15 mL in 1 BOTTLESOLUTION152
55045-1243-0acetic acid1 in 1 BOXSOLUTION12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55045-1243ACETIC ACID SOLUTION [DISPENSING SOLUTIONS, INC.]2Legacy NDC, 2 package rows20130712_53d97ebe-fdf0-47af-ba93-a4a3327981de.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55045-1243-0ML - Milliliter55045-124338f782ba-52ce-41f1-86d2-7bc4b26b82df12013-08-02
50383-889-15ML - Milliliter50383-8896dbe6614-0a52-4e15-9a38-8c5bb9ed81fd12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ACETIC ACIDACTIVE INGREDIENTQ40Q9N063P2
ACETIC ACIDACTIVE MOIETYQ40Q9N063P2
BENZETHONIUM CHLORIDEINACTIVE INGREDIENTPH41D057442
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
PROPYLENE GLYCOL DIACETATEINACTIVE INGREDIENT5Z492UNF9O2
SODIUM ACETATEINACTIVE INGREDIENT4550K0SC9B2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55045-124355045-1243-0
50383-889

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 122 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS63.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / SUBLINGUAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSUSPENSION / AURICULAR (OTIC)0.68 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, SOLUBLE / BUCCAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / OPHTHALMIC0.44 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSOLUTION / OPHTHALMIC2 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / OPHTHALMIC0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, POWDER, FOR SOLUTION / PARENTERAL12.5 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CONCENTRATE / ORAL7000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / RECTAL90400 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAVENOUS4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, METERED / RECTALNAExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / INTRASYNOVIALADJ PHExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / OPHTHALMIC0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / TOPICAL1800 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / RESPIRATORY (INHALATION)10 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BLIQUID / SUBCUTANEOUS0.2 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZETHONIUM CHLORIDEBENZETHONIUM CHLORIDEPH41D05744INJECTION / INTRAMUSCULAR1 mgExact identifier — unii candidate
6 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TAMPON / VAGINAL62.1 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / TOPICAL0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOL DIACETATEPROPYLENE GLYCOL DIACETATE5Z492UNF9OSOLUTION / AURICULAR (OTIC)3 %w/vExact identifier — unii candidate
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / AURICULAR (OTIC)56.55 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3PASTE / DENTAL0.5 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / OPHTHALMIC0.6 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUPPOSITORY / VAGINAL252 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL / TOPICAL19.2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
32 equally ranked IID candidates
BENZETHONIUM CHLORIDEBENZETHONIUM CHLORIDEPH41D05744INJECTION / INTRAVENOUS1 mgExact identifier — unii candidate
6 equally ranked IID candidates
BENZETHONIUM CHLORIDEBENZETHONIUM CHLORIDEPH41D05744INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS0.5 mgExact identifier — unii candidate
6 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSOLUTION / ORAL44 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / ORAL29008 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LOTION / TOPICAL3392 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / SOFT TISSUEADJ PHExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOL DIACETATEPROPYLENE GLYCOL DIACETATE5Z492UNF9OSOLUTION/ DROPS / AURICULAR (OTIC)46 mgExact identifier — unii candidate
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / OPHTHALMIC1 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / VAGINAL1225 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY, METERED / NASAL240 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION, EXTENDED RELEASE / ORAL1000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / OPHTHALMIC1.5 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSOLUTION / AURICULAR (OTIC)0.02 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SHAMPOO / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, SOLUTION / SUBMUCOSAL0.08 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYRUP / ORAL5700 mgExact identifier — unii candidate
81 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N012179-001VOSOLACETIC ACID, GLACIAL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION/DROPS / OTICRLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N012179-001VOSOL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION/DROPS / OTICRLD, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N012179-001VOSOL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION/DROPS / OTICRLD, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N012179-001VOSOL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION/DROPS / OTICRLD, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N012179-001VOSOL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION/DROPS / OTICRLD, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N012179-001VOSOL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION/DROPS / OTICRLD, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N012179-001VOSOL2%SOLUTION/DROPS / OTICRLD, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N012179-001VOSOL2%SOLUTION/DROPS / OTICATApproved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N012179-001VOSOL2%SOLUTION/DROPS / OTICATRS, Approved before 1982f41ea6bd6efb…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012179-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N012179-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N012179-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N012179-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N012179-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N012179-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N012179-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03N012179-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N012179-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N012179-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N012179-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09N012179-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07N012179-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N012179-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N012179-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N012179-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N012179-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N012179-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N012179-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N012179-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05N012179-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01N012179-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N012179-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N012179-001AT1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N012179-001AT1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N012179-001AT1cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e0f01554-43e3-4ed2-afef-d9fa4f539e5453d97ebe-fdf0-47af-ba93-a4a3327981de2013-07-12Warnings, Adverse reactionsExact identifier
spl id: e0f01554-43e3-4ed2-afef-d9fa4f539e54
spl set id: 53d97ebe-fdf0-47af-ba93-a4a3327981de

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.